Lenalidomide and Peripheral sensorimotor neuropathy - a phase IV clinical study of FDA data

Summary:

Peripheral sensorimotor neuropathy is reported as a side effect among people who take Lenalidomide (lenalidomide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Zoledronic Acid, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Peripheral sensorimotor neuropathy when taking Lenalidomide. It is created by eHealthMe based on reports of 52,873 people who have side effects when taking Lenalidomide from the FDA, and is updated regularly.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

What is Peripheral sensorimotor neuropathy?

Peripheral sensorimotor neuropathy (damage to one or more of your peripheral nerves) is found to be associated with 185 drugs and 323 conditions by eHealthMe. Check the latest studies of Peripheral sensorimotor neuropathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

52,873 people reported to have side effects when taking Lenalidomide.
Among them, 13 people (0.02%) have Peripheral sensorimotor neuropathy.

Could Lenalidomide cause Peripheral sensorimotor neuropathy?

Among these 13 people:

How long have people been on Lenalidomide when they have Peripheral sensorimotor neuropathy? *

What is the gender of people who have Peripheral sensorimotor neuropathy when taking Lenalidomide? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Peripheral sensorimotor neuropathy when taking Lenalidomide? *

What are other drugs people take besides Lenalidomide? *

What are other side effects people have besides Peripheral sensorimotor neuropathy? *

Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 4 people, 30.77%
Sinusitis (inflammation of sinus): 4 people, 30.77%
Parkinson's Disease: 4 people, 30.77%
Osteonecrosis Of Jaw (death of bone of jaw): 4 people, 30.77%
Herpes Zoster: 4 people, 30.77%
Drug Eruption (adverse drug reaction of the skin): 4 people, 30.77%
Skin Exfoliation (removal of the oldest dead skin cells): 2 people, 15.38%
Sinus Disorder (disease of sinus): 2 people, 15.38%
Rhinorrhea (watery mucus discharge from the nose): 2 people, 15.38%
Upper Respiratory Tract Infection: 2 people, 15.38%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 84.62%
Urinary Tract Infection: 1 person, 7.69%
Spinal Cord Compression: 1 person, 7.69%
Infusion Related Reaction: 1 person, 7.69%
Hypokalemia (low potassium): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Lenalidomide and have Peripheral sensorimotor neuropathy?

- Check whether Peripheral sensorimotor neuropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lenalidomide:

Lenalidomide (52,881 reports)

Browse all side effects of Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral sensorimotor neuropathy:

Peripheral sensorimotor neuropathy (185 drugs)

Browse all the conditions that are associated with Peripheral sensorimotor neuropathy:

Peripheral sensorimotor neuropathy (323 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Lenalidomide) and Lenalidomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.